Lataa...
In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST
BACKGROUND AND PURPOSE: Candida glabrata is the second cause of candidiasis. The mortality rate of C. glabrata infections is about 40%; accordingly, it may be life threatening, especially in immunocompromised hosts. Regarding this, the current study was conducted to evaluate the regional patterns of...
Tallennettuna:
| Julkaisussa: | Curr Med Mycol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Iranian Society of Medical Mycology
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7888517/ https://ncbi.nlm.nih.gov/pubmed/33628974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/CMM.6.2.2692 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|